ERBB4 and breast carcinoma: In our study, KKP HR cells expressed high levels of nuclear HER4, confirming recent findings about the involvement of HER4, especially in terms of its activation, cleavage and nuclear translocation, in resistance to trastuzumab in breast cancer cell lines [31, 49].